Dissolution studies in the presence of alcohol with an abuse-deterrent, extended-release morphine product candidate

被引：0
|
作者：
Elhauge, T. [1 ]
Kristensen, L. [1 ]
Dayno, J. [1 ]
Lindhardt, K. [1 ]
机构：
[1] Egalet Corp, Wayne, PA USA
来源：
JOURNAL OF PAIN | 2016年 / 17卷 / 04期
关键词：
D O I：
10.1016/j.jpain.2016.01.402
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
425
引用
收藏
页码：S80 / S81
页数：2
相关论文
共 50 条
  • [1] Syringeability of morphine ARER, a novel, abuse-deterrent, extended-release morphine formulation
    Kinzler, Eric R.
    Pantaleon, Carmela
    Iverson, Matthew S.
    Aigner, Stefan
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2019, 45 (04): : 377 - 384
  • [2] Human abuse potential studies of abuse-deterrent opioids: lessons from oral and intranasal studies with morphine abuse-deterrent, extended-release, injection-molded tablets
    Webster, Lynn R.
    Viscusi, Eugene R.
    Brown, Colville
    Dayno, Jeffrey M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (05) : 893 - 901
  • [3] The Clinical Applications of Extended-Release Abuse-Deterrent Opioids
    Nalini Vadivelu
    Erika Schermer
    Gopal Kodumudi
    Jack M. Berger
    CNS Drugs, 2016, 30 : 637 - 646
  • [4] The Clinical Applications of Extended-Release Abuse-Deterrent Opioids
    Vadivelu, Nalini
    Schermer, Erika
    Kodumudi, Gopal
    Berger, Jack M.
    CNS DRUGS, 2016, 30 (07) : 637 - 646
  • [5] Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) vs Extended-Release Morphine Administered Intranasally in Nondependent Recreational Opioid Users
    Webster, Lynn R.
    Smith, Michael D.
    Lawler, John
    Lindhardt, Karsten
    Dayno, Jeffrey M.
    PAIN MEDICINE, 2017, 18 (09) : 1695 - 1705
  • [6] Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) versus Extended-Release Morphine Administered Orally in Nondependent Recreational Opioid Users
    Smith, Michael D.
    Webster, Lynn R.
    Lawler, John
    Lindhardt, Karsten
    Dayno, Jeffrey M.
    PAIN MEDICINE, 2017, 18 (05) : 898 - 907
  • [7] Bioequivalence and food effect of a novel, abuse-deterrent (AD), extended-release (ER) morphine product candidate compared with a currently available non-AD, ER morphine product
    Dayno, J.
    Lawler, J.
    Niebler, G.
    Lindhardt, K.
    JOURNAL OF PAIN, 2016, 17 (04): : S82 - S82
  • [8] Extraction testing of a novel extended-release, abuse-deterrent formulation of morphine, Morphine ARER, in common household solvents
    Bianchi, R.
    Kinzler, E.
    DiFalco, R.
    Shah, M.
    Aigner, S.
    JOURNAL OF PAIN, 2014, 15 (04): : S77 - S77
  • [9] Pharmacodynamic effects from a category 3 intranasal human abuse potential study of an abuse-deterrent, extended-release morphine product candidate in nondependent, recreational opioid users
    Webster, L.
    Smith, M.
    Lawler, J.
    Lindhardt, K.
    Dayno, J.
    JOURNAL OF PAIN, 2016, 17 (04): : S80 - S80
  • [10] The Effect of Abuse-Deterrent Extended-Release Oxycodone Leads to Inappropriate Conclusions with Over Estimation of Safety of Abuse-Deterrent Formulations
    Manchikanti, Laxmaiah
    Atluri, Sairam
    Hirsch, Joshua A.
    PAIN PHYSICIAN, 2015, 18 (03) : E445 - E446
12345